These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Statin treatment and 3' polyadenylation of eNOS mRNA. Kosmidou I; Moore JP; Weber M; Searles CD Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2642-9. PubMed ID: 17916773 [TBL] [Abstract][Full Text] [Related]
4. Blockade of geranylgeranylation by rosuvastatin upregulates eNOS expression in human venous endothelial cells. Landsberger M; Jantzen F; Könemann S; Felix SB Biochem Biophys Res Commun; 2005 Nov; 336(4):1005-9. PubMed ID: 16165089 [TBL] [Abstract][Full Text] [Related]
5. Statins ameliorate endothelial barrier permeability changes in the cerebral tissue of streptozotocin-induced diabetic rats. Mooradian AD; Haas MJ; Batejko O; Hovsepyan M; Feman SS Diabetes; 2005 Oct; 54(10):2977-82. PubMed ID: 16186401 [TBL] [Abstract][Full Text] [Related]
6. Statins Prevent Dextrose-Induced Endoplasmic Reticulum Stress and Oxidative Stress in Endothelial and HepG2 Cells. Kojanian H; Szafran-Swietlik A; Onstead-Haas LM; Haas MJ; Mooradian AD Am J Ther; 2016; 23(6):e1456-e1463. PubMed ID: 24800792 [TBL] [Abstract][Full Text] [Related]
7. Involvement of the p38 pathway in the differential induction of heme oxygenase-1 by statins in Neuro-2A cells exposed to lipopolysaccharide. Hsieh CH; Jeng JC; Hsieh MW; Chen YC; Lu TH; Rau CS; Jeng SF Drug Chem Toxicol; 2011 Jan; 34(1):8-19. PubMed ID: 20954800 [TBL] [Abstract][Full Text] [Related]
8. Simvastatin and rosuvastatin mobilize Endothelial Progenitor Cells but do not prevent their acute decrease during systemic inflammation. Spiel AO; Mayr FB; Leitner JM; Firbas C; Sieghart W; Jilma B Thromb Res; 2008; 123(1):108-13. PubMed ID: 18433844 [TBL] [Abstract][Full Text] [Related]
9. Statins and angiogenesis: is it about connections? Khaidakov M; Wang W; Khan JA; Kang BY; Hermonat PL; Mehta JL Biochem Biophys Res Commun; 2009 Sep; 387(3):543-7. PubMed ID: 19615978 [TBL] [Abstract][Full Text] [Related]
10. Suppression of hyperglycemia-induced superoxide formation and endothelin-1 gene expression by carvedilol. Horani MH; Haas MJ; Mooradian AD Am J Ther; 2006; 13(1):2-7. PubMed ID: 16428915 [TBL] [Abstract][Full Text] [Related]
11. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells. Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646 [TBL] [Abstract][Full Text] [Related]
12. The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose. Piconi L; Corgnali M; Da Ros R; Assaloni R; Piliego T; Ceriello A J Diabetes Complications; 2008; 22(1):38-45. PubMed ID: 18191076 [TBL] [Abstract][Full Text] [Related]
13. Effects of rosuvastatin on fibrinolytic system of human umbilical vein endothelial cells in vitro. He F; Zhao J; Guo R; Liang Y Am J Med Sci; 2014 Oct; 348(4):319-23. PubMed ID: 24694789 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression. Tabuchi T; Satoh M; Itoh T; Nakamura M Clin Sci (Lond); 2012 Aug; 123(3):161-71. PubMed ID: 22364258 [TBL] [Abstract][Full Text] [Related]
15. Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient mice. Enomoto S; Sata M; Fukuda D; Nakamura K; Nagai R Biomed Pharmacother; 2009 Jan; 63(1):19-26. PubMed ID: 18162361 [TBL] [Abstract][Full Text] [Related]
16. Inhibitors of HMG-CoA reductase reduce receptor-mediated endocytosis in human kidney proximal tubular cells. Verhulst A; D'Haese PC; De Broe ME J Am Soc Nephrol; 2004 Sep; 15(9):2249-57. PubMed ID: 15339974 [TBL] [Abstract][Full Text] [Related]
17. Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells. Lazzerini PE; Capperucci C; Spreafico A; Capecchi PL; Niccolini S; Ferrata P; Frediani B; Galeazzi M; Laghi-Pasini F Joint Bone Spine; 2013 Mar; 80(2):195-200. PubMed ID: 22999910 [TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin treatment protects against nitrate-induced oxidative stress in eNOS knockout mice: implication of the NAD(P)H oxidase pathway. Otto A; Fontaine J; Tschirhart E; Fontaine D; Berkenboom G Br J Pharmacol; 2006 Jun; 148(4):544-52. PubMed ID: 16633368 [TBL] [Abstract][Full Text] [Related]
19. Rosuvastatin promotes osteoblast differentiation and regulates SLCO1A1 transporter gene expression in MC3T3-E1 cells. Monjo M; Rubert M; Ellingsen JE; Lyngstadaas SP Cell Physiol Biochem; 2010; 26(4-5):647-56. PubMed ID: 21063102 [TBL] [Abstract][Full Text] [Related]
20. Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects. Sironi L; Gianazza E; Gelosa P; Guerrini U; Nobili E; Gianella A; Cremonesi B; Paoletti R; Tremoli E Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):598-603. PubMed ID: 15681303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]